Slide background
Slide background




EMA | Questions & Answers MD and In Vitro Diagnostic MD

ID 12505 | | Visite: 567 | Documenti Marcatura CE ENTIPermalink: https://www.certifico.com/id/12505

Questions Answers MD and In Vitro Diagnostic MD

Questions & Answers MD and In Vitro Diagnostic MD

European Medicines Agency, Oct. 2019 / Update 

Update: EMA will update its regulatory guidance in the first quarter of 2021 to reflect the new date of application of the Regulation MD 26 May 2021.

Questions & Answers on Implementation of the Medical Devices and In Vitro Diagnostic Medical Devices Regulations ((EU) 2017/745 and (EU) 2017/746)

Regulation (EU) 2017/745 application postponed from 26 May 2020 at 26 May 2021 from Regulation (EU) 2020/561.

1. Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)
2. Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes. This update of the questions and answers focuses on aspects relating to the implementation and applicability of the requirements of Regulation (EU) 2017/745 to medicinal products with an integral or co-packaged medical device.

This Question and Answer (Q&A) document provides practical considerations concerning the implementation of the medical devices and the in vitro diagnostic medical devices regulations. This document has been produced to provide guidance to Applicants as regards aspects falling within the scope of the Agency’s activities and should be read in conjunction with the new medical devices Regulation (EU) 2017/745, and the new in vitro diagnostic medical devices Regulation (EU) 2017/746.

The medical devices regulation (MDR) and in-vitro diagnostics regulation (IVDR) replace the three existing Directives (93/42/EEC98/79/EC and 90/385/EEC) for medical devices.

The Regulations entered into force on 25 May 2017; however, they will have a transition period to allow manufacturers, notified bodies and authorities to comply with the changes and will come into full application on 26 May 2020  (postponed at 26 May 2021 from Regulation (EU) 2020/561) for medical devices and 26 May 2022 for in vitro diagnostics.

These regulations lay down roles and responsibilities for EMA and National Competent Authorities (NCA) for medicinal products, as follows:

- For medical devices incorporating a medicinal substance (with action ancillary to the device) the notified body shall seek a scientific opinion from either the NCAs or EMA. The notified body shall seek the opinion of EMA for medicinal products falling exclusively within the scope of centralized procedure , or that incorporate human blood or plasma derivatives
- For devices that are composed of substances or of combinations of substances that are systemically absorbed by the body in order to achieve their intended purpose, the notified body shall seek a scientific opinion from either the NCAs or the EMA
- For companion diagnostics, the notified body shall seek a scientific opinion from either the NCAs or the EMA
- The European Commission may consult EMA when deliberating on the regulatory status of products in borderline cases involving medicinal products
- For medicinal products with an integral medical device, there are new requirements to provide an opinion from a notified body

This is a living document and the questions and answers are being updated continuously, and will be marked by “NEW” or “Rev.” with the relevant date upon publication.

Table of contents
1. Medicinal product medical device combinations (‘combination products’)
1.1. What regulatory framework does a product incorporating both medicinal product and medical device fall under? New Oct 2019
1.2. How do I choose a notified body for my co-packaged /integral device? New Oct 2019
2. Medicinal product with an integral medical device (integral DDC)
2.1. When is my medicinal product considered to form an integral product with the administration device?
2.2. What is Article 117 and what does it mean for medicinal products? Rev. Oct 2019
2.3. How will the medical devices Regulation and in particular Article 117 impact new marketing authorisation applications? Rev. Oct 2019
2.4. When is it required to provide the notified body opinion/ EU certificate / declaration of conformity with my Marketing Authorisation Application (MAA)? Rev. Oct 2019
2.5. At what stage do I need to submit the notified body opinion?
2.6. How does Article 117 of the medical devices regulation impact currently authorised integral DDCs? Rev. Oct 2019
2.7. Will I need to provide a (new or updated) EU certificate / declaration of conformity / notified body opinion if there are changes to the device submitted through a variation /extension?
2.8. What is the impact of the MDR on medicinal products including an integral medical device for a Mutual Recognition Procedure submitted on or after the 26 May 2020? New Oct 2019.
2.9. Are the requirements for UDI (unique device identifier) applicable to integral DDCs? New Oct 2019
3. Medicinal product with a co-packaged device
3.1. How will the implementation of the Medical Device Regulation affect the device? New Oct 2019
...

Fonte: EMA

Collegati:

 


Tags: Marcatura CE Abbonati Marcatura CE Regolamento Dispositivi Medici Regolamento DMD Vitro

Ultimi archiviati Marcatura CE

Set 08, 2021 46

Direttiva 79/196/CEE

Direttiva 79/196/CEE Direttiva 79/196/CEE del Consiglio, del 6 febbraio 1979, riguardante il ravvicinamento delle legislazioni degli Stati Membri relative al materiale elettrico destinato ad essere utilizzato in atmosfera esplosiva, per il quale si applicano taluni metodi di protezione (GU L 43 del… Leggi tutto
Set 08, 2021 33

Direttiva 82/130/CEE

Direttiva 82/130/CEE Direttiva 82/130/CEE del Consiglio, del 15 febbraio 1982, riguardante il ravvicinamento delle legislazioni degli Stati Membri relative al materiale elettrico destinato ad essere utilizzato in atmosfera esplosiva nelle miniere grisutose (GU L 59 del 2.3.1982) Abrogata… Leggi tutto
Set 08, 2021 37

Legge 17 aprile 1989 n. 150

Legge 17 aprile 1989 n. 150 Attuazione della direttiva 82/130/CEE e norme transitorie concernenti la costruzione e la vendita di materiale elettrico destinato ad essere utilizzato in atmosfera esplosiva. (GU n.97 del 27.04.1989) Entrata in vigore della legge: 28/4/1989_______ Aggiornamenti all'atto… Leggi tutto
Set 08, 2021 31

Direttiva 76/117/CEE

Direttiva 76/117/CEE Direttiva 76/117/CEE del Consiglio, del 18 dicembre 1975, riguardante il ravvicinamento delle legislazioni degli Stati Membri relative al materiale elettrico destinato ad essere utilizzato in «atmosfera esplosiva» (GU L 24 del 30.1.197) Abrogata da: Direttiva 94/9/CE… Leggi tutto
Set 08, 2021 30

DPR 21 luglio 1982 n. 727

DPR 21 luglio 1982 n. 727 Attuazione della direttiva (CEE) n. 76/117 relativa al materiale elettrico destinato ad essere utilizzato in "atmosfera esplosiva". (GU n.281 del 12.10.1982) Collegati
Direttiva 76/117/CEEDirettiva 94/9/CE ATEXNuova Direttiva ATEX Prodotti 2014/34/UE
Leggi tutto
Set 08, 2021 31

DPR 21 luglio 1982 n. 675

DPR 21 luglio 1982 n. 675 Attuazione della direttiva (CEE) n. 196 del 1979 relativa al materiale elettrico destinato ad essere utilizzato in atmosfera esplosiva, per il quale si applicano taluni metodi di protezione. (GU n.264 del 24.09.1982) Collegati[box-note]Direttiva 79/196/CEEDirettiva 94/9/CE… Leggi tutto
Ago 24, 2021 96

Regolamento Delegato (UE) 2021/1398

Regolamento Delegato (UE) 2021/1398 Regolamento Delegato (UE) 2021/1398 della Commissione del 4 giugno 2021 che modifica il regolamento delegato (UE) 2017/654 che integra il regolamento (UE) 2016/1628 del Parlamento europeo e del Consiglio per quanto riguarda l’accettazione delle omologazioni… Leggi tutto

Più letti Marcatura CE

Giu 26, 2019 68414

Regolamento Prodotti da Costruzione (UE) 305/2011 - CPR

Regolamento CPR (UE) 305/2011 Regolamento (UE) N. 305/2011 del Parlamento Europeo e del Consiglio del 9 marzo 2011 che fissa condizioni armonizzate per la commercializzazione dei prodotti da costruzione e che abroga la direttiva 89/106/CEE del Consiglio (Testo rilevante ai fini del SEE) GU L 88/10… Leggi tutto